Role of viral factors in modifying weight-related effects on disease progression of chronic hepatitis C patients.
Hsu
Ching-Sheng
CS
Kao
Jia-Horng
JH
D000998:Antiviral Agents / Q000627:therapeutic use; D018450:Disease Progression; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics / Q000502:physiology*; D019698:Hepatitis C, Chronic / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D009765:Obesity / Q000503:physiopathology*; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011994:Recombinant Proteins; D016896:Treatment Outcome; D019562:Viral Load / Q000502:physiology*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a